Ferrán Barbé Illa-rekin lankidetzan egindako argitalpenak (67)

2020

  1. Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea

    Thorax, Vol. 75, Núm. 6, pp. 459-467

  2. Differential blood pressure response to continuous positive airway pressure treatment according to the circadian pattern in hypertensive patients with obstructive sleep apnoea

    European Respiratory Journal, Vol. 54, Núm. 1

  3. Echocardiographic changes with positive airway pressure therapy in obesity hypoventilation syndrome long-term pickwick randomized controlled clinical trial

    American Journal of Respiratory and Critical Care Medicine, Vol. 201, Núm. 5, pp. 586-597

  4. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 4, pp. 359-367

  5. Eficacia y coste-efectividad del diagnóstico y decisión terapéutica de la apnea obstructiva del sueño en atención primaria: descripción de la metodología.

    Revista española de patología torácica, Vol. 32, Núm. 4, pp. 260-274

  6. Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial

    Chest, Vol. 158, Núm. 3, pp. 1176-1186

  7. The effect of sleep apnea on cardiovascular events in different acute coronary syndrome phenotypes

    American Journal of Respiratory and Critical Care Medicine, Vol. 202, Núm. 12, pp. 1698-1706

  8. Upcoming Scenarios for the Comprehensive Management of Obstructive Sleep Apnea: An Overview of the Spanish Sleep Network

    Archivos de Bronconeumologia, Vol. 56, Núm. 1, pp. 35-41